ISTH 2026 preview highlighting competitive developments in hemophilia, von Willebrand disease, anticoagulation and AI diagnostics.

ISTH 2026 Preview: Hemophilia, VWD and Anticoagulation Market Trends

ISTH 2026 at a glance ISTH 2026 brings emerging competitive dynamics into focus…


Rare Disease Today

Rare Diseases Today—June 25, 2026

This week’s Rare Diseases update highlights regulatory milestones,…


Lucid Diligence Brief - BioPharma

Pfizer's HYMPAVZI FDA label expansion | Lucid Diligence Brief

Pfizer’s HYMPAVZI FDA label expansion covers children 6–11 and patients ≥12…


Hematology

Hematology Today—April 27, 2026

This week’s Hematology update highlights regulatory approvals, extended review…


Mobile Health Apps Trends

Health Mobile Apps Landscape in H2 2025

Trending in Health Mobile Apps: Current Trends, Rankings and Insights from H2…


EAHAD 2026_Preview_by_LucidQuest

EAHAD 2026 PREVIEW: Key Highlights to Watch

EAHAD 2026 at a Glance Get ready for EAHAD 2026. LucidQuest’s preview…


Hematology

Hematology Today—February 2, 2026

This weekly update in Hematology covers regulatory actions, late-stage clinical…


Rare Disease news

Rare Disease Today—January 8, 2026

This rare disease update covers major regulatory approvals, strategic…


Hematology

Hematology Video Recap—December 15, 2025

This biweekly hematology update covers major regulatory decisions, late-stage…


Hematology

Hematology Today—December 15, 2025

This week’s hematology update spotlights key developments, regulatory…


Cell_Gene_Therapy

Cell and Gene Therapy Today—December 4, 2025

This week’s Cell & Gene Therapy update highlights major gene-editing…


Hematology

Hematology Weekly News - September 29th 2025

Hematology Update: Advanced HDP-101 Cohort, Pivotal Ziftomenib Data, Pediatric…


Privacy Preference Center